|
US5837276A
(en)
|
1994-09-02 |
1998-11-17 |
Delab |
Apparatus for the delivery of elongate solid drug compositions
|
|
US5688520A
(en)
*
|
1995-03-29 |
1997-11-18 |
Minnesota Mining And Manufacturing Company |
Transmucosal delivery of melatonin for prevention of migraine
|
|
US6290969B1
(en)
*
|
1995-09-01 |
2001-09-18 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
|
US6592877B1
(en)
*
|
1995-09-01 |
2003-07-15 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
|
US6458366B1
(en)
|
1995-09-01 |
2002-10-01 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
|
DE19631085A1
(de)
*
|
1996-08-01 |
1998-02-05 |
Basf Ag |
Verwendung von (Meth)acrylsäure-Maleinsäure-Copolymeren zur Verbesserung der Permeabilität der Schleimhaut
|
|
US6458574B1
(en)
|
1996-09-12 |
2002-10-01 |
Transkaryotic Therapies, Inc. |
Treatment of a α-galactosidase a deficiency
|
|
US6083725A
(en)
*
|
1996-09-13 |
2000-07-04 |
Transkaryotic Therapies, Inc. |
Tranfected human cells expressing human α-galactosidase A protein
|
|
DE19646392A1
(de)
*
|
1996-11-11 |
1998-05-14 |
Lohmann Therapie Syst Lts |
Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
|
|
US20020018754A1
(en)
*
|
1999-03-15 |
2002-02-14 |
Paul Albert Sagel |
Shapes for tooth whitening strips
|
|
US6096328A
(en)
|
1997-06-06 |
2000-08-01 |
The Procter & Gamble Company |
Delivery system for an oral care substance using a strip of material having low flexural stiffness
|
|
US6582708B1
(en)
|
2000-06-28 |
2003-06-24 |
The Procter & Gamble Company |
Tooth whitening substance
|
|
US6248358B1
(en)
|
1998-08-25 |
2001-06-19 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets and methods of making and using the same
|
|
US6624200B2
(en)
|
1998-08-25 |
2003-09-23 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
|
US8765177B2
(en)
*
|
1997-09-12 |
2014-07-01 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
|
US20020147143A1
(en)
|
1998-03-18 |
2002-10-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
CN1221249C
(zh)
|
1998-08-19 |
2005-10-05 |
斯凯伊药品加拿大公司 |
普鲁泊福的可注射水分散体
|
|
US20030235557A1
(en)
|
1998-09-30 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
|
US7001609B1
(en)
|
1998-10-02 |
2006-02-21 |
Regents Of The University Of Minnesota |
Mucosal originated drug delivery systems and animal applications
|
|
US6984404B1
(en)
|
1998-11-18 |
2006-01-10 |
University Of Florida Research Foundation, Inc. |
Methods for preparing coated drug particles and pharmaceutical formulations thereof
|
|
US8143386B2
(en)
*
|
1999-04-07 |
2012-03-27 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
|
US6319510B1
(en)
|
1999-04-20 |
2001-11-20 |
Alayne Yates |
Gum pad for delivery of medication to mucosal tissues
|
|
US6406745B1
(en)
*
|
1999-06-07 |
2002-06-18 |
Nanosphere, Inc. |
Methods for coating particles and particles produced thereby
|
|
US6756382B2
(en)
*
|
1999-06-10 |
2004-06-29 |
3M Innovative Properties Company |
Amide substituted imidazoquinolines
|
|
US6331539B1
(en)
*
|
1999-06-10 |
2001-12-18 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
|
USRE42126E1
(en)
|
1999-07-02 |
2011-02-08 |
The Procter & Gamble Company |
Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
|
|
EP1229931A4
(de)
*
|
1999-10-07 |
2003-05-28 |
Corixa Corp |
Fusionsproteine aus mycobacterium tuberculosis
|
|
US20020110585A1
(en)
|
1999-11-30 |
2002-08-15 |
Godbey Kristin J. |
Patch therapeutic agent delivery device having texturized backing
|
|
SI1650221T1
(sl)
|
2000-02-23 |
2012-09-28 |
Glaxosmithkline Biolog Sa |
Nove spojine
|
|
WO2001062893A2
(en)
|
2000-02-25 |
2001-08-30 |
Corixa Corporation |
Compounds and methods for diagnosis and immunotherapy of tuberculosis
|
|
PT2133100E
(pt)
|
2000-06-20 |
2012-01-11 |
Corixa Corp |
Antigénio mtb32a de mycobacterium tuberculosis com um local activo inactivado e suas proteínas de fusão
|
|
EP1319069B1
(de)
|
2000-06-28 |
2008-05-21 |
Corixa Corporation |
Zusammensetzungen und verfahren für therapie und diagnose von lungenkrebs
|
|
ES2271034T3
(es)
*
|
2000-06-28 |
2007-04-16 |
THE PROCTER & GAMBLE COMPANY |
Estructuras y composiciones que incrementan la estabilidad de sustancias activas de tipo peroxido.
|
|
GB0016693D0
(en)
|
2000-07-07 |
2000-08-23 |
Procter & Gamble |
Cough treatment
|
|
US7803392B2
(en)
|
2000-12-27 |
2010-09-28 |
University Of Kentucky Research Foundation |
pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
|
|
CA2446788A1
(en)
|
2001-05-09 |
2002-11-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US6585997B2
(en)
|
2001-08-16 |
2003-07-01 |
Access Pharmaceuticals, Inc. |
Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
|
|
US20060073174A1
(en)
*
|
2001-08-16 |
2006-04-06 |
Access Pharmaceuticals, Inc. |
Adherent and erodible film to treat a moist surface of a body tissue
|
|
EP1581119B1
(de)
|
2001-12-17 |
2013-01-30 |
Corixa Corporation |
Zusammensetzungen und verfahren zur behandlung und diagnose von entzündlicher darmerkrankung
|
|
US20030124178A1
(en)
*
|
2001-12-28 |
2003-07-03 |
Haley Jeffrey T. |
Soft, adherent, soluble oral patch
|
|
US20050226915A1
(en)
*
|
2001-12-28 |
2005-10-13 |
Oramelts Corporation, A Washington Corporation |
Method for manufacturing and packaging oral patches with rounded edges
|
|
AU2003213118A1
(en)
*
|
2002-02-15 |
2003-09-09 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
|
DK1503788T3
(da)
|
2002-04-25 |
2011-10-17 |
Shire Human Genetic Therapies |
Behandling af alpha-galactosidase A-deficiens
|
|
US6949240B2
(en)
*
|
2002-05-23 |
2005-09-27 |
The Procter & Gamble Company |
Tooth whitening products
|
|
US8956160B2
(en)
*
|
2002-07-02 |
2015-02-17 |
Ranir, Llc |
Device and method for delivering an oral care agent
|
|
US8524200B2
(en)
|
2002-09-11 |
2013-09-03 |
The Procter & Gamble Company |
Tooth whitening products
|
|
KR100501827B1
(ko)
*
|
2002-09-24 |
2005-07-20 |
한국화학연구원 |
다층 코팅법을 이용한 멜라토닌 함유 타게팅 약물 전달 기구
|
|
US7960522B2
(en)
|
2003-01-06 |
2011-06-14 |
Corixa Corporation |
Certain aminoalkyl glucosaminide phosphate compounds and their use
|
|
SI1589934T1
(sl)
|
2003-01-06 |
2016-02-29 |
Corixa Corporation Corporation Service Company |
Določene aminoalkil glukozaminid fosfat spojine in njih uporaba
|
|
AU2004257373B2
(en)
|
2003-07-16 |
2011-03-24 |
Arbutus Biopharma Corporation |
Lipid encapsulated interfering RNA
|
|
WO2005018556A2
(en)
|
2003-08-12 |
2005-03-03 |
3M Innovative Properties Company |
Hydroxylamine substituted imidazo-containing compounds
|
|
RU2006105101A
(ru)
|
2003-08-27 |
2007-10-10 |
3М Инновейтив Пропертиз Компани (US) |
Арилокси и арилалкиленокси замещенные имидазохинолины
|
|
WO2005023190A2
(en)
|
2003-09-05 |
2005-03-17 |
3M Innovative Properties Company |
Treatment for cd5+ b cell lymphoma
|
|
US8871782B2
(en)
|
2003-10-03 |
2014-10-28 |
3M Innovative Properties Company |
Alkoxy substituted imidazoquinolines
|
|
US7544697B2
(en)
|
2003-10-03 |
2009-06-09 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridines and analogs thereof
|
|
US8598192B2
(en)
|
2003-11-14 |
2013-12-03 |
3M Innovative Properties Company |
Hydroxylamine substituted imidazoquinolines
|
|
CA2545774A1
(en)
|
2003-11-14 |
2005-06-02 |
3M Innovative Properties Company |
Oxime substituted imidazo ring compounds
|
|
AR046781A1
(es)
|
2003-11-25 |
2005-12-21 |
3M Innovative Properties Co |
Derivados de imidazoquinolinas. composiciones farmaceuticas.
|
|
WO2005066170A1
(en)
|
2003-12-29 |
2005-07-21 |
3M Innovative Properties Company |
Arylalkenyl and arylalkynyl substituted imidazoquinolines
|
|
CA2551399A1
(en)
|
2003-12-30 |
2005-07-21 |
3M Innovative Properties Company |
Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
|
|
CA2552677A1
(en)
|
2004-01-13 |
2005-07-28 |
Vasogenix Pharmaceuticals, Inc. |
Controlled release cgrp delivery composition for cardiovascular and renal indications
|
|
AU2005228150A1
(en)
|
2004-03-24 |
2005-10-13 |
3M Innovative Properties Company |
Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
|
|
CA2568201C
(en)
|
2004-05-24 |
2013-07-30 |
Universitat Zu Koln |
Identification of ergothioneine transporter and therapeutic uses thereof
|
|
AU2005285513B2
(en)
|
2004-05-25 |
2011-02-24 |
Oregon Health And Science University |
SIV and HIV vaccination using RhCMV- and HCMV-based vaccine vectors
|
|
WO2005123080A2
(en)
|
2004-06-15 |
2005-12-29 |
3M Innovative Properties Company |
Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
|
|
WO2006065280A2
(en)
|
2004-06-18 |
2006-06-22 |
3M Innovative Properties Company |
Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
|
|
WO2006038923A2
(en)
|
2004-06-18 |
2006-04-13 |
3M Innovative Properties Company |
Aryl substituted imidazonaphthyridines
|
|
US8026366B2
(en)
|
2004-06-18 |
2011-09-27 |
3M Innovative Properties Company |
Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
|
|
US10583094B2
(en)
|
2004-09-18 |
2020-03-10 |
University Of Maryland |
Therapeutic methods that target the NCCA-ATP channel
|
|
JP5085326B2
(ja)
|
2004-09-18 |
2012-11-28 |
ユニバーシティ オブ メリーランド,ボルチモア |
NCCa−ATPチャネルを標的とする処置剤およびその使用方法
|
|
US20060099550A1
(en)
*
|
2004-11-10 |
2006-05-11 |
Ranir/Dcp Corporation |
Device and method for delivering an oral care agent
|
|
US20060134201A1
(en)
*
|
2004-12-16 |
2006-06-22 |
Haley Jeffrey T |
Collagen troches for treating mouth lesions
|
|
EP1831226B1
(de)
|
2004-12-30 |
2012-08-08 |
3M Innovative Properties Company |
Chirale tetracyklische verbindungen, die interferon biosyntheze induzieren
|
|
AU2005326708C1
(en)
|
2004-12-30 |
2012-08-30 |
3M Innovative Properties Company |
Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
|
|
AU2006210392A1
(en)
|
2005-02-04 |
2006-08-10 |
Coley Pharmaceutical Group, Inc. |
Aqueous gel formulations containing immune response modifiers
|
|
CA2597587A1
(en)
|
2005-02-11 |
2006-08-17 |
Coley Pharmaceutical Group, Inc. |
Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
|
|
DE102005015128B4
(de)
*
|
2005-03-31 |
2008-12-11 |
Bayer Schering Pharma Aktiengesellschaft |
Wafer enthaltend Steroidhormone
|
|
CN101184504A
(zh)
|
2005-03-31 |
2008-05-21 |
葛兰素史密丝克莱恩生物有限公司 |
针对衣原体感染的疫苗
|
|
US7943636B2
(en)
|
2005-04-01 |
2011-05-17 |
3M Innovative Properties Company |
1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
|
|
WO2006107853A2
(en)
|
2005-04-01 |
2006-10-12 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridine-1,4-diamines and analogs thereof
|
|
JP5749881B2
(ja)
|
2005-04-22 |
2015-07-15 |
ユニヴェルシテ デ ジュネーブ |
ポリラクチド組成物およびその使用
|
|
PT2426141E
(pt)
|
2005-04-29 |
2014-11-25 |
Glaxosmithkline Biolog Sa |
Método para prevenção ou tratamento de uma infecção por m. tuberculosis
|
|
EP1948674A4
(de)
|
2005-11-02 |
2009-02-04 |
Protiva Biotherapeutics Inc |
Modifizierte sirna-moleküle und anwendungen davon
|
|
EP1956910B1
(de)
|
2005-11-23 |
2014-09-17 |
The Board of Regents of The University of Texas System |
Für onkogenes ras spezifische cytotoxische verbindung und verfahren zu ihrer verwendung
|
|
WO2007120368A2
(en)
|
2006-01-09 |
2007-10-25 |
The Regents Of The University Of California |
Immunostimulatory combinations for vaccine adjuvants
|
|
US8349120B2
(en)
*
|
2006-03-07 |
2013-01-08 |
Ora Health Corporation |
Multi-layer patch made on a sheet and enclosed in a blister
|
|
US8524454B2
(en)
|
2006-04-07 |
2013-09-03 |
The Research Foundation Of State University Of New York |
Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
|
|
US20070248655A1
(en)
*
|
2006-04-21 |
2007-10-25 |
Haley Jeffrey T |
Lenticular shaped protective mouth sore discs
|
|
US20070248654A1
(en)
*
|
2006-04-21 |
2007-10-25 |
Haley Jeffrey T |
Protective mouth sore discs made with corn starch
|
|
US7906506B2
(en)
|
2006-07-12 |
2011-03-15 |
3M Innovative Properties Company |
Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
|
|
WO2008089103A2
(en)
|
2007-01-12 |
2008-07-24 |
University Of Maryland, Baltimore |
Targeting ncca-atp channel for organ protection following ischemic episode
|
|
EP2120580B1
(de)
|
2007-02-02 |
2017-12-27 |
Baylor College Of Medicine |
Zusammensetzungen und verfahren zur behandlung von stoffwechselerkrankungen
|
|
WO2008124647A2
(en)
|
2007-04-04 |
2008-10-16 |
Infectious Disease Research Institute |
Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof
|
|
DK2623605T3
(en)
|
2007-04-09 |
2019-03-25 |
Univ Florida |
RAAV VECTOR COMPOSITIONS WITH TYROSIN MODIFIED CAPSIDE PROTEINS AND PROCEDURES FOR USE THEREOF
|
|
CA2691199C
(en)
|
2007-06-22 |
2017-09-12 |
Marc J. Simard |
Inhibitors of ncca-atp channels for therapy
|
|
ES2725450T3
(es)
|
2007-07-02 |
2019-09-24 |
Etubics Corp |
Métodos y composiciones para la producción de un vector adenoviral para su uso en vacunaciones múltiples
|
|
US9006191B2
(en)
|
2007-12-27 |
2015-04-14 |
Protiva Biotherapeutics, Inc. |
Silencing of polo-like kinase expression using interfering RNA
|
|
CA2714340A1
(en)
*
|
2008-02-13 |
2009-08-20 |
Bayer Schering Pharma Aktiengesellschaft |
Estradiol-containing drug delivery system
|
|
AU2009214307A1
(en)
*
|
2008-02-13 |
2009-08-20 |
Bayer Intellectual Property Gmbh |
Drug delivery system with stabilising effect
|
|
EP2279254B1
(de)
|
2008-04-15 |
2017-07-05 |
Protiva Biotherapeutics Inc. |
Neue lipidformulierungen zur nukleinsäurezuführung
|
|
WO2009129319A2
(en)
|
2008-04-15 |
2009-10-22 |
Protiva Biotherapeutics, Inc. |
Silencing of csn5 gene expression using interfering rna
|
|
EP2310498A1
(de)
|
2008-06-26 |
2011-04-20 |
Atyr Pharma, Inc. |
Glycyl-trna-synthetasen mit nichtkanonischen biologischen aktivitäten umfassende zusammensetzungen und verfahren
|
|
US20110263478A1
(en)
|
2008-09-16 |
2011-10-27 |
Simard J Marc |
Sur1 inhibitors for therapy
|
|
US8765817B1
(en)
|
2008-12-03 |
2014-07-01 |
Arrowhead Center, Inc. |
Selective inhibitors of EG5 motors and methods of use
|
|
US8349899B1
(en)
|
2008-12-03 |
2013-01-08 |
Arrowhead Center, Inc. |
Selective inhibitors of EG5 motors and methods of use
|
|
ES2552773T3
(es)
|
2009-02-27 |
2015-12-02 |
Atyr Pharma, Inc. |
Motivos estructurales de polipéptidos asociados con la actividad de señalización celular
|
|
JP5730280B2
(ja)
|
2009-03-16 |
2015-06-03 |
パング バイオファーマ リミテッド |
非カノニカル生物学的活性を有するヒスチジル−tRNAシンテターゼスプライスバリアントを含む組成物および方法
|
|
WO2010120509A2
(en)
|
2009-03-31 |
2010-10-21 |
Atyr Pharma, Inc. |
Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities
|
|
WO2010135714A2
(en)
|
2009-05-22 |
2010-11-25 |
The Methodist Hospital Research Institute |
Methods for modulating adipocyte expression using microrna compositions
|
|
ES2613498T3
(es)
|
2009-07-01 |
2017-05-24 |
Protiva Biotherapeutics Inc. |
Nuevas formulaciones de lípidos para el suministro de agentes terapéuticos a tumores sólidos
|
|
WO2011011447A1
(en)
|
2009-07-20 |
2011-01-27 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing ebola virus gene expression
|
|
EP2954780A1
(de)
|
2009-07-24 |
2015-12-16 |
Baylor College Of Medicine |
Verfahren zur modulierung von säuren mit verzweigten letten und anwendungen davon
|
|
WO2011038160A2
(en)
|
2009-09-23 |
2011-03-31 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing genes expressed in cancer
|
|
CN102770152B
(zh)
|
2009-11-25 |
2016-07-06 |
阿瑞斯根股份有限公司 |
肽类的粘膜递送
|
|
US20110150885A1
(en)
|
2009-12-11 |
2011-06-23 |
Atyr Pharma, Inc. |
Aminoacyl trna synthetases for modulating hematopoiesis
|
|
ES2535951T3
(es)
|
2009-12-11 |
2015-05-19 |
Atyr Pharma, Inc. |
Histidil ARNt sintetasas para reducir la inflamación
|
|
LT2528621T
(lt)
|
2010-01-27 |
2016-12-12 |
Glaxosmithkline Biologicals S.A. |
Modifikuoti tuberkuliozės antigenai
|
|
CA2797093C
(en)
|
2010-04-26 |
2019-10-29 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
|
|
CA2797362C
(en)
|
2010-04-27 |
2020-12-08 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
|
|
WO2011139853A2
(en)
|
2010-04-28 |
2011-11-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
|
|
US8986680B2
(en)
|
2010-04-29 |
2015-03-24 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
|
|
EP2563383B1
(de)
|
2010-04-29 |
2017-03-01 |
Atyr Pharma, Inc. |
Innovative entdeckung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen im zusammenhang mit proteinfragmenten von valyl-trna-synthetasen
|
|
CN103140233B
(zh)
|
2010-05-03 |
2017-04-05 |
Atyr 医药公司 |
与甲硫氨酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的发现
|
|
WO2011139986A2
(en)
|
2010-05-03 |
2011-11-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
|
|
CA2797977C
(en)
|
2010-05-03 |
2019-08-20 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
|
|
EP2566499B1
(de)
|
2010-05-04 |
2017-01-25 |
aTyr Pharma, Inc. |
Innovative entdeckung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen im zusammenhang mit proteinfragmenten aus einem p38-multi-trna-synthetase-komplex
|
|
US10077232B2
(en)
|
2010-05-12 |
2018-09-18 |
Arbutus Biopharma Corporation |
Cyclic cationic lipids and methods of use
|
|
US20130123338A1
(en)
|
2010-05-12 |
2013-05-16 |
Protiva Biotherapeutics, Inc. |
Novel cationic lipids and methods of use thereof
|
|
CA2799197C
(en)
|
2010-05-14 |
2019-10-29 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
|
|
US9034598B2
(en)
|
2010-05-17 |
2015-05-19 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
|
|
AU2011258106B2
(en)
|
2010-05-27 |
2017-02-23 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases
|
|
CN103118694B
(zh)
|
2010-06-01 |
2016-08-03 |
Atyr医药公司 |
与赖氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的发现
|
|
JP6116479B2
(ja)
|
2010-07-12 |
2017-04-19 |
エータイアー ファーマ, インコーポレイテッド |
グリシルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
|
EP2606152B2
(de)
|
2010-08-18 |
2025-03-12 |
Fred Hutchinson Cancer Center |
Verfahren zur bestimmung des vorhandenseins oder risikos der entwicklung fazioskapulohumeraler muskeldystrophie (fshd)
|
|
JP5964304B2
(ja)
|
2010-08-25 |
2016-08-03 |
エータイアー ファーマ, インコーポレイテッド |
チロシルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
|
US20130345079A1
(en)
|
2010-10-27 |
2013-12-26 |
Infectious Disease Research Institute |
Mycobacterium tuberculosis antigens and combinations thereof having high seroreactivity
|
|
EP2637687B1
(de)
|
2010-11-08 |
2021-01-06 |
Infectious Disease Research Institute |
Impfstoffe mit nichtspezifischer nukleosidhydrolase und sterol-24-c-methyltransferase (smt)-polypeptiden zur behandlung und diagnose von leishmaniose
|
|
CN103476791A
(zh)
|
2011-01-11 |
2013-12-25 |
菲特治疗公司 |
新型wnt组合物和该组合物的治疗用途
|
|
WO2012103328A1
(en)
|
2011-01-26 |
2012-08-02 |
The Methodist Hospital Research Institute |
Labeled, non- peptidic multivalent integrin alpha -v - beta - 3 antagonists, compositions containing them and their use
|
|
DK2717922T3
(en)
|
2011-06-10 |
2019-01-07 |
Bluebird Bio Inc |
GENERATIVE VECTORS FOR ADDRENOLEUCODYSTROPHY AND ADDRENOMYELONE EUROPE
|
|
JP2014527398A
(ja)
|
2011-06-21 |
2014-10-16 |
オンコファクター コーポレイション |
がんの療法および診断のための組成物および方法
|
|
DK2734634T3
(da)
|
2011-07-22 |
2019-10-21 |
Univ Chicago |
Igf-1 til anvendelse til behandling af migræne
|
|
WO2013057592A2
(en)
|
2011-09-14 |
2013-04-25 |
King Abdullah University Of Science And Technology |
Treatment of sickle cell disease
|
|
WO2013041969A2
(en)
|
2011-09-21 |
2013-03-28 |
King Abdullah University Of Science And Technology |
Didemnin biosynthetic gene cluster in tistrella mobilis
|
|
WO2013095736A2
(en)
|
2011-09-27 |
2013-06-27 |
The Methodist Hospital Research Institute |
Gold-in-silicon nanoassembly for thermal therapy and methods of use
|
|
CA2850484C
(en)
|
2011-09-30 |
2021-01-26 |
Bluebird Bio, Inc. |
Compounds for improved viral transduction
|
|
WO2013071154A1
(en)
|
2011-11-11 |
2013-05-16 |
Fred Hutchinson Cancer Research Center |
Cyclin a1-targeted t-cell immunotherapy for cancer
|
|
EP2780456A1
(de)
|
2011-11-17 |
2014-09-24 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Therapeutische rna schalter-zusammensetzungen und anwendungsverfahren dafür
|
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
|
EP2814514B1
(de)
|
2012-02-16 |
2017-09-13 |
Atyr Pharma, Inc. |
Histidyl-trna-synthetasen zur behandlung von autoimmun- und entzündungserkrankungen
|
|
US20150024037A1
(en)
|
2012-02-16 |
2015-01-22 |
The University Of Toledo |
Xenoantigen-Displaying Anti-Cancer Vaccines and Method of Making
|
|
US9352042B2
(en)
|
2012-02-24 |
2016-05-31 |
Protiva Biotherapeutics, Inc. |
Trialkyl cationic lipids and methods of use thereof
|
|
AR092821A1
(es)
|
2012-04-20 |
2015-05-06 |
Sucampo Ag |
Conjugado de derivado de acido graso-polimero
|
|
CA2874490C
(en)
|
2012-05-23 |
2021-11-16 |
The Ohio State University |
Tertiary quaternary amine-based cationic lipid nanoparticle compositions and methods of making and methods of using the same
|
|
EP4299138A3
(de)
|
2012-08-03 |
2024-08-14 |
Access to Advanced Health Institute |
Zusammensetzungen und verfahren zur behandlung einer aktiven mycobakterium-tuberkuloseinfektion
|
|
US9605276B2
(en)
|
2012-08-24 |
2017-03-28 |
Etubics Corporation |
Replication defective adenovirus vector in vaccination
|
|
PL2908798T3
(pl)
|
2012-10-17 |
2019-02-28 |
Procter & Gamble |
Pasek do wprowadzania środka aktywującego higienę jamy ustnej i sposoby stosowania środków aktywujących higienę jamy ustnej
|
|
WO2014160339A1
(en)
|
2013-03-13 |
2014-10-02 |
Board Of Regents, The University Of Texas System |
Compounds for treating inflammatory and hyperproliferative diseases
|
|
CN114717206A
(zh)
|
2013-03-15 |
2022-07-08 |
Atyr 医药公司 |
组氨酰-trna合成酶-fc缀合物
|
|
EP2978447B1
(de)
|
2013-03-28 |
2019-05-08 |
Infectious Disease Research Institute |
Impfstoffe mit leishmania-polypeptiden zur behandlung und diagnose von leishmaniase
|
|
WO2015011633A1
(en)
|
2013-07-23 |
2015-01-29 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for delivering messenger rna
|
|
EP3077412B1
(de)
|
2013-12-02 |
2023-01-04 |
Baylor College of Medicine |
Identifizierung eines neuen polypeptidhormons zur aufrechterhaltung eines optimalen körpergewichts und glucosewerts
|
|
BR112017004349A2
(pt)
|
2014-09-04 |
2017-12-05 |
Memorial Sloan Kettering Cancer Center |
terapia com gene de globina para o tratamento de hemoglobinopatias
|
|
WO2016040695A1
(en)
|
2014-09-10 |
2016-03-17 |
C.R. Bard, Inc. |
Protective dressing for skin-placed medical device
|
|
CN104257636A
(zh)
*
|
2014-09-26 |
2015-01-07 |
天津市聚星康华医药科技有限公司 |
一种溶菌酶口腔贴膜及其制备方法
|
|
US10415037B2
(en)
|
2014-10-02 |
2019-09-17 |
Arbutus Biopharma Corporation |
Compositions and methods for silencing hepatitis B virus gene expression
|
|
WO2016073184A1
(en)
|
2014-11-04 |
2016-05-12 |
Dana Farber Cancer Institute, Inc. |
Compositions and methods for treating multiple myeloma
|
|
AU2016205215B2
(en)
|
2015-01-09 |
2021-03-11 |
Etubics Corporation |
Methods and compositions for combination immunotherapy
|
|
US11149087B2
(en)
|
2015-04-20 |
2021-10-19 |
Etubics Corporation |
Methods and compositions for combination immunotherapy
|
|
WO2016197132A1
(en)
|
2015-06-04 |
2016-12-08 |
Protiva Biotherapeutics Inc. |
Treating hepatitis b virus infection using crispr
|
|
US10962551B2
(en)
|
2015-06-17 |
2021-03-30 |
The Johns Hopkins University |
TDP-43 in degenerative disease
|
|
CN108350455A
(zh)
|
2015-07-29 |
2018-07-31 |
阿布特斯生物制药公司 |
用于使b型肝炎病毒基因表达沉默的组合物和方法
|
|
AU2017212713B2
(en)
|
2016-01-27 |
2023-01-19 |
Oncorus, Inc. |
Oncolytic viral vectors and uses thereof
|
|
US10695322B2
(en)
|
2016-01-29 |
2020-06-30 |
The Johns Hopkins University |
Inhibitors of bacterial growth
|
|
WO2017143112A2
(en)
|
2016-02-17 |
2017-08-24 |
The Johns Hopkins University |
An oxazolidinone for treatment of infections with mycobacterium tuberculosis
|
|
US11180758B2
(en)
|
2016-02-24 |
2021-11-23 |
The Johns Hopkins University |
Antiviral proteins and their uses in therapeutic methods
|
|
WO2017155935A1
(en)
|
2016-03-07 |
2017-09-14 |
The Johns Hopkins University |
Pharmaceutical agents targeting cancer stem cells
|
|
MX2018010850A
(es)
|
2016-03-10 |
2019-05-15 |
Univ Johns Hopkins |
Métodos para producir proteínas de fusión de toxina diftérica monoméricas y libres de agregados y usos terapéuticos.
|
|
US11965009B2
(en)
|
2016-03-10 |
2024-04-23 |
The Johns Hopkins University |
Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
|
|
US11203626B2
(en)
|
2016-03-10 |
2021-12-21 |
The Johns Hopkins University |
Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
|
|
KR102889062B1
(ko)
|
2016-03-17 |
2025-11-21 |
더 존스 홉킨스 유니버시티 |
Paris의 파네실화에 의해 파킨슨병을 예방 또는 치료하기 위한 방법
|
|
EP3436609B1
(de)
|
2016-03-30 |
2022-05-04 |
The Johns Hopkins University |
Olfr90-spezifität und nachweisverfahren
|
|
US11016085B2
(en)
|
2016-04-25 |
2021-05-25 |
The Johns Hopkins University |
ZNT8 assays for drug development and pharmaceutical compositions
|
|
EP3458088A2
(de)
|
2016-05-21 |
2019-03-27 |
Infectious Disease Research Institute |
Zusammensetzungen und verfahren zur behandlung von sekundärer tuberkulose und nichttuberkulösen mykobakterium-infektionen
|
|
EP3735984A1
(de)
|
2016-05-27 |
2020-11-11 |
Etubics Corporation |
Neoepitop-impfstoffzusammensetzungen und verfahren zur verwendung davon
|
|
US11191849B2
(en)
|
2016-06-30 |
2021-12-07 |
Arbutus Biopharma Corporation |
Compositions and methods for delivering messenger RNA
|
|
WO2018039131A1
(en)
|
2016-08-22 |
2018-03-01 |
Protiva Biotherapeutics, Inc. |
Anti-pd-1 antibodies, or fragments thereof, for treating hepatitis b
|
|
WO2018053294A1
(en)
|
2016-09-16 |
2018-03-22 |
Infectious Disease Research Institute |
Vaccines comprising mycobacterium leprae polypeptides for the prevention, treatment, and diagnosis of leprosy
|
|
US11149275B2
(en)
|
2016-10-10 |
2021-10-19 |
The Johns Hopkins University |
Device and method to treat esophageal disorders
|
|
AU2017379901B2
(en)
|
2016-12-21 |
2024-02-15 |
Arbutus Biopharma Corporation |
Methods for ameliorating infusion reactions
|
|
US10434089B2
(en)
|
2017-01-25 |
2019-10-08 |
The Johns Hopkins University |
Avibactam and carbapenems antibacterial agents
|
|
BR112019018912A2
(pt)
|
2017-03-14 |
2020-04-14 |
Baylor College Of Medicine |
yap ativo dominante, um hipoefetor, induz acessibilidade de cromatina e renovação de cardiomiócito
|
|
US20210139932A1
(en)
|
2017-05-03 |
2021-05-13 |
Biomarin Pharmaceutical Inc. |
Improved lentiviruses for transduction of hematopoietic stem cells
|
|
CN111316099A
(zh)
|
2017-07-12 |
2020-06-19 |
约翰霍普金斯大学 |
用于1型糖尿病诊断的基于脂蛋白体的znt8自身抗原
|
|
MX2020000993A
(es)
|
2017-07-26 |
2020-07-22 |
Oncorus Inc |
Vectores virales oncolíticos y usos de estos.
|
|
EP3678695A1
(de)
|
2017-09-08 |
2020-07-15 |
Infectious Disease Research Institute |
Liposomale formulierungen enthaltend saponin und verwendungsverfahren
|
|
US20200330541A1
(en)
|
2017-11-16 |
2020-10-22 |
University Of Maine System Board Of Trustees |
Compositions and methods for modulating endothelial cell migration and angiogenesis
|
|
EP3720509A4
(de)
|
2017-12-06 |
2021-12-08 |
Memorial Sloan-Kettering Cancer Center |
Globingentherapie zur behandlung von hämoglobinopathien
|
|
WO2019118527A1
(en)
|
2017-12-14 |
2019-06-20 |
The Johns Hopkins University |
Novel anti-fungal inhibitors
|
|
TW201936201A
(zh)
|
2017-12-14 |
2019-09-16 |
美商堅固生物科技公司 |
基因之非病毒生產及遞送
|
|
EP3743102A1
(de)
|
2018-01-26 |
2020-12-02 |
Nantcell, Inc. |
Zusammensetzungen und verfahren zur kombination eines krebsimpfstoffs und einer immunologischen adjuvanten therapie
|
|
WO2019148147A1
(en)
|
2018-01-29 |
2019-08-01 |
The Johns Hopkins University |
Polymeric nanoparticle compositions for encapsulation and sustained release of protein therapeutics
|
|
EP3762401A4
(de)
|
2018-03-06 |
2021-12-08 |
The Johns Hopkins University |
Kombination von abgereicherten tregs und einem kontrollpunktinhibitor
|
|
KR102167755B1
(ko)
|
2018-05-23 |
2020-10-19 |
주식회사 큐어바이오 |
단편화된 grs 폴리펩타이드, 이의 변이체 및 이들의 용도
|
|
KR20210071949A
(ko)
|
2018-07-29 |
2021-06-16 |
무스크 파운데이션 포 리서치 디벨롭먼트 |
신경학적 질환 또는 미트콘드리아 질환 치료용 화합물
|
|
US12226433B2
(en)
|
2018-08-06 |
2025-02-18 |
The Johns Hopkins University |
Treatment of irritable bowel syndrome with molybdenum
|
|
WO2020037174A1
(en)
|
2018-08-16 |
2020-02-20 |
The Johns Hopkins University |
Antibodies to human znt8
|
|
US20220096600A1
(en)
|
2019-02-07 |
2022-03-31 |
Baylor College Of Medicine |
Periosteal skeletal stem cells in bone repair
|
|
US11717506B2
(en)
|
2019-05-07 |
2023-08-08 |
The Johns Hopkins University |
Neuroprotective compounds for amyotrophic lateral sclerosis
|
|
CA3145456A1
(en)
|
2019-07-01 |
2021-01-07 |
Orion Corporation |
Methods for administering (r)-n-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]acetamide
|
|
US10758329B1
(en)
|
2019-08-20 |
2020-09-01 |
Raymond L. Wright, III |
Hydrating mouth guard
|
|
US12366570B2
(en)
|
2019-10-01 |
2025-07-22 |
The Johns Hopkins University |
Cell-based ZNT8 assay
|
|
CN114765990A
(zh)
|
2019-10-10 |
2022-07-19 |
昂克诺斯公司 |
双重病毒和双重溶瘤病毒以及治疗方法
|
|
US20230026352A1
(en)
|
2019-12-26 |
2023-01-26 |
Figene, Llc |
Suppression of interleukin-17 production and inhibition of th17 cell generation by fibroblasts and products thereof
|
|
AU2020412623A1
(en)
|
2019-12-26 |
2022-07-14 |
Figene, Llc |
Prevention and treatment of kidney failure by administration of fibroblasts and products thereof
|
|
TW202200121A
(zh)
|
2020-03-16 |
2022-01-01 |
美商費斯特威弗生技股份有限公司 |
治療方法
|
|
JP7709981B2
(ja)
|
2020-03-17 |
2025-07-17 |
ジェネヴァント サイエンシズ ゲーエムベーハー |
肝星細胞への治療薬の脂質ナノ粒子送達のためのカチオン性脂質
|
|
AU2021321944A1
(en)
|
2020-08-07 |
2023-04-06 |
Access To Advanced Health Institute |
Purified saponins and chromatographic process for purification of same
|
|
US20230310323A1
(en)
|
2020-09-04 |
2023-10-05 |
Access To Advanced Health Institute |
Co-lyophilized rna and nanostructured lipid carrier
|
|
WO2022051024A1
(en)
|
2020-09-04 |
2022-03-10 |
Infectious Disease Research Institute |
Genetically-adjuvanted rna vaccines
|
|
WO2022051023A1
(en)
|
2020-09-04 |
2022-03-10 |
Infectious Disease Research Institute |
Live-attenuated rna hybrid vaccine technology
|
|
EP4221729A4
(de)
|
2020-10-01 |
2025-03-12 |
The Johns Hopkins University |
Bcg-basierte impfstoffzusammensetzungen und verfahren zur verwendung davon
|
|
KR20220082558A
(ko)
|
2020-12-10 |
2022-06-17 |
재단법인 의약바이오컨버젼스연구단 |
면역 증진 활성이 있는 신규 crs 단편 펩타이드 및 이의 용도
|
|
AU2021403156A1
(en)
|
2020-12-18 |
2023-07-13 |
Genevant Sciences Gmbh |
Peg lipids and lipid nanoparticles
|
|
TW202313065A
(zh)
|
2021-05-28 |
2023-04-01 |
美商季卡尼醫療公司 |
用於治療遺傳疾病之化合物
|
|
KR20240146674A
(ko)
|
2022-01-31 |
2024-10-08 |
제네반트 사이언시즈 게엠베하 |
지질 나노입자를 위한 이온화 가능한 양이온성 지질
|
|
WO2023144792A1
(en)
|
2022-01-31 |
2023-08-03 |
Genevant Sciences Gmbh |
Poly(alkyloxazoline)-lipid conjugates and lipid particles containing same
|
|
EP4519438A1
(de)
|
2022-05-05 |
2025-03-12 |
The Board of Trustees of the Leland Stanford Junior University |
Interferierende rna-therapie für pln-r14del-kardiomyopathie
|
|
WO2023235380A1
(en)
|
2022-06-01 |
2023-12-07 |
Zikani Therapeutics, Inc. |
Macrolides for treating genetic diseases
|
|
WO2023250513A1
(en)
|
2022-06-24 |
2023-12-28 |
Zikani Therapeutics, Inc. |
13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
|
|
JP2025530776A
(ja)
|
2022-09-01 |
2025-09-17 |
ジカニ セラピューティクス, インコーポレイテッド |
13員環マクロライドを使用した家族性大腸腺腫症の処置
|
|
CN120882864A
(zh)
|
2022-09-30 |
2025-10-31 |
国立大学法人 东京大学 |
靶向il13ra2的单纯疱疹病毒及抗il13ra2抗体或其抗原结合片段
|
|
WO2025052278A1
(en)
|
2023-09-05 |
2025-03-13 |
Genevant Sciences Gmbh |
Pyrrolidine based cationic lipids for lipid nanoparticle delivery of therapeutics to hepatic stellate cells
|
|
WO2025133951A1
(en)
|
2023-12-21 |
2025-06-26 |
Genevant Sciences Gmbh |
Ionizable lipids suitable for lipid nanoparticles
|